3.8 C
London
Tuesday, February 11, 2025
HomeFinance NewsUS judge denies blocking Medicare's ability to negotiate drug prices

US judge denies blocking Medicare’s ability to negotiate drug prices

Date:

Related stories

Federal Judge Orders Trump Administration to Unfreeze Funding Immediately

U.S. District Court Judge John McConnell has been identified...

Nazis, Racists, and “Big Balls,” Oh My!

The Nation: Elon Musk’s supporters, often referred to as...

February 11, 2025 Wordle: Today’s Answer and Hints

For those interested in engaging with Wordle, Mashable once...

Judge to Decide if Elon Musk Can Access Treasury Records

DOGE faced a lawsuit alleging that Elon Musk's team...

EU Plans Response to US Steel and Aluminium Tariffs

The European Union has announced plans to respond to...
spot_img

A federal judge in Ohio has ruled that the U.S. government’s Medicare health insurance program can begin negotiating prices for certain prescription drugs starting this fall. The decision is a victory for President Joe Biden’s effort to lower healthcare costs. The ruling comes in response to a lawsuit filed by the U.S. Chamber of Commerce, claiming that the program violates the U.S. Constitution and would stifle innovation. However, Judge Michael Newman rejected this argument, stating that drugmakers are not being forced to participate in Medicare and therefore the program does not constitute a constitutional violation.

The program, which is part of the Inflation Reduction Act signed by President Biden last year, aims to save $25 billion annually by 2031 by requiring drugmakers to negotiate prices with the U.S. Centers for Medicare and Medicaid Services. Medicare primarily serves Americans aged 65 and older. Drugmakers whose medicines were selected for the first round of negotiations must agree to begin talks on October 1st, or else face steep penalties or potential exclusion from government healthcare programs. The negotiated prices would take effect in 2026, with a minimum discount of 25% off the list price.

While the ruling allows the program to proceed as planned, the lawsuit will continue, denying a government motion to dismiss it altogether. This ruling is the first among multiple lawsuits filed by drug companies and industry groups challenging the program. The Chamber of Commerce’s lawsuit is the most advanced among them, as other cases are moving at a slower pace and may not be ruled upon until next year. The Biden administration remains committed to reducing healthcare costs for American families, despite challenges from Republicans and the pharmaceutical industry.

Source link

DMN8 Partners
DMN8 Partnershttps://salvonow.com/
DMN8 Partners utilizes a strategy of Cross Channel marketing including local search engine optimization, PPC, messaging and hyper-targeted audiences allow our clients to experience results and ROI that fuel growth and expansion in their operations. There are a lot of digital marketing options across the country but partnering with an agency that understands multiple touches on multiple platforms allows your company’s message to be seen at the perfect time, on the perfect platform, by your perfect prospect. DMN8 Partners has had years of experience growing businesses. Start growing your business today and begin DOMINATE-ing your market.